WM
RGNX icon

WS Management’s Regenxbio RGNX Stock Holding History

WS Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-300,000
Closed -$3.15M – 55
2024
Q3 		$3.15M Sell
300,000
-79,059
-21% -$964K 0.22% 43
2024
Q2 		$4.43M Hold
379,059
– – 0.33% 46
2024
Q1 		$7.99M Sell
379,059
-52,141
-12% -$928K 0.5% 39
2023
Q4 		$7.74M Sell
431,200
-186,931
-30% -$3.29M 0.46% 43
2023
Q3 		$10.2M Sell
618,131
-177,647
-22% -$3.22M 0.82% 36
2023
Q2 		$15.9M Buy
795,778
+398,781
+100% +$7.68M 1.33% 24
2023
Q1 		$7.51M Hold
396,997
– – 0.79% 31
2022
Q4 		$9M Hold
396,997
– – 0.77% 32
2022
Q3 		$10.5M Sell
396,997
-20,000
-5% -$593K 0.95% 24
2022
Q2 		$10.3M Sell
416,997
-57,303
-12% -$1.43M 0.84% 27
2022
Q1 		$15.7M Buy
474,300
+189,000
+66% +$5.25M 0.77% 19
2021
Q4 		$9.33M Buy
285,300
+74,571
+35% +$2.54M 0.74% 30
2021
Q3 		$8.83M Sell
210,729
-50,000
-19% -$1.8M 0.93% 25
2021
Q2 		$10.1M Sell
260,729
-69,600
-21% -$2.49M 1% 28
2021
Q1 		$11.3M Buy
330,329
+72,400
+28% +$3.09M 1.17% 23
2020
Q4 		$11.7M Sell
257,929
-178,899
-41% -$6.25M 1.21% 21
2020
Q3 		$12M Hold
436,828
– – 1.3% 18
2020
Q2 		$16.1M Sell
436,828
-198,933
-31% -$7.42M 1.97% 9
2020
Q1 		$20.6M Sell
635,761
-85,739
-12% -$3.57M 2.25% 10
2019
Q4 		$29.6M Sell
721,500
-236,465
-25% -$9.34M 2.53% 11
2019
Q3 		$34.1M Sell
957,965
-41,763
-4% -$1.69M 2.66% 12
2019
Q2 		$51.4M Buy
999,728
+3,968
+0.4% +$198K 3.33% 6
2019
Q1 		$57.1M Sell
995,760
-20,260
-2% -$1M 3.46% 8
2018
Q4 		$42.6M Buy
1,016,020
+61,208
+6% +$3.59M 2.08% 12
2018
Q3 		$72.1M Sell
954,812
-84,163
-8% -$6.06M 2.37% 10
2018
Q2 		$74.5M Buy
1,038,975
+838,975
+419% +$40.1M 2.1% 12
2018
Q1 		$5.97M Buy
+200,000
New +$5.82M 0.16% 57

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WS Management's RGNX Position: Q4 2024 in Review

WS Management sold out of Regenxbio (RGNX) in Q4 2024, closing a stake of 300,000 shares — an estimated $3.15M sold.

WS Management first reported a position in RGNX in Q1 2018 and held it in 27 quarters. The position peaked at $74.5M in Q2 2018. 177 funds tracked by Wall St. Rank hold RGNX as of Q4 2024.

  • WS Management reported no remaining Regenxbio position as of Q4 2024 after selling out during the quarter.
  • WS Management sold 300,000 Regenxbio shares in Q4 2024, an estimated $3.15M.
  • WS Management first reported a position in Regenxbio in Q1 2018 and held it in 27 quarters.
  • WS Management's Regenxbio position peaked at $74.5M in Q2 2018.
  • 177 funds tracked by Wall St. Rank held Regenxbio as of Q4 2024.

Based on WS Management's 13F filing for Q4 2024, filed 14 Feb 2025.